pCODR

A Comparison of Proposed INESSS and Current CADTH Evaluation Fees   On February 21, 2018, the Quebec government released draft regulations (Gazette Officielle du Québec) that outline fees payable to Institut national d'excellence en santé et en services sociaux (INESSS) for the scientific evaluation of a drug or stable blood product. The fees are expected to vary based on the type of dossier submitted for scientific review with INESSS determining…

Changes, Updates and Reminders Related to CDR Guidelines   On Friday, June 9th, CADTH issued a CDR Update with a number of changes, updates, and reminders that are worth reviewing. The key highlights are: Two Process Changes Guidance for Subsequent Entry Non-Biological Complex Drugs Revised Documentation for Resubmissions Two Reminders (In-person CDR Meetings/Confidential Prices) Communication with Consultants Further detail, which has been drawn from the CDR Update, can be found…

CAPCA has initiated consultations with stakeholders on its recent initiative aimed at addressing the challenges facing the oncology drug system.   The Canadian Association of Provincial Cancer Agencies (CAPCA) recently held its first set of round-table sessions (Vancouver and Toronto) with pharmaceutical industry representatives and patient groups to discuss the pan-Canadian Cancer Drug Funding Sustainability (DFS) Initiative. This initiative was initially introduced via webinars in January and February 2017 and…